The financials
Bausch Health Companies Inc. by the numbers
Bausch Health Companies Inc. (BHC) reported revenue of $2.52B in Q1 2026 (quarter ended March 31, 2026), up 12% from the same quarter a year earlier. That came with net loss of $1.43B. For the full year FY2025, revenue was $10.3B (+6.7% year on year) and net income $120M. Its largest region in 2024-Q3 was United Statesand Puerto Rico at $1.53B, 61% of the disclosed total, just ahead of Other Countries at 10%.
| Income statement | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $2.52B | $2.26B | +12% |
| Operating income | −$950M | $276M | to a loss |
| Net income | −$1.43B | −$86M | n/a |
| Diluted EPS | −$3.82 | −$0.16 | n/a |
| Geographic | Revenue | Share |
|---|---|---|
| United Statesand Puerto Rico | $1.53B | 61% |
| Other Countries | $263M | 10% |
| CN | $132M | 5.3% |
| CA | $104M | 4.1% |
| PL | $92M | 3.7% |
| MX | $88M | 3.5% |
| FR | $52M | 2.1% |
| JP | $46M | 1.8% |
| RU | $42M | 1.7% |
| DE | $40M | 1.6% |
| KR | $38M | 1.5% |
| GB | $34M | 1.4% |
| IT | $23M | 0.9% |
| ES | $21M | 0.8% |
Business Segments
Revenue split by geographic segment, from SEC XBRL filings.
Latest period: Q3 2024Total $2.51B (+4.5%)
KR grew +58% year on yearMX -2.2% year on year
Segment Latestquarter on quarteryear on year
- United States and Puerto Rico$1.53B$1.53BQoQ +6.7%year on year +13%+6.7%+13%
- Other Countries$263.0M$263.0MQoQ -3.3%year on year +8.7%-3.3%+8.7%
- CN$132.0M$132.0MQoQ +8.2%year on year +17%+8.2%+17%
- CA$104.0M$104.0MQoQ +5.1%year on year +13%+5.1%+13%
- PL$92.0M$92.0MQoQ +18%year on year +12%+18%+12%
- MX$88.0M$88.0MQoQ +4.8%year on year -2.2%+4.8%-2.2%
- FR$52.0M$52.0MQoQ -20%year on year +6.1%-20%+6.1%
- JP$46.0M$46.0MQoQ -2.1%year on year -2.1%-2.1%-2.1%
- RU$42.0M$42.0MQoQ +7.7%year on year +20%+7.7%+20%
- DE$40.0M$40.0MQoQ -2.4%year on year +18%-2.4%+18%
- KR$38.0M$38.0MQoQ +12%year on year +58%+12%+58%
- GB$34.0M$34.0MQoQ +3.0%year on year +6.3%+3.0%+6.3%
- IT$23.0M$23.0MQoQ -4.2%year on year +15%-4.2%+15%
- ES$21.0M$21.0MQoQ -22%year on year +5.0%-22%+5.0%
Drug Manufacturers - Specialty & Generic
Ranks #20 of 28 by Smart Score